Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-047421)

Filing Details

Accession Number:: 0001140361-12-047421
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-11-14 20:26:04
Reporting Period:: 2012-10-31

Filing Date:: 2012-11-14
Accepted Time:: 2012-11-14 20:26:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557533	Robert Jeffrey Ajer	C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949	Svp, Chief Commercial Of	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-10-31	265	$21.76	10,835	No	5	A	Direct
Common Stock	Disposition	2012-11-12	265	$48.11	10,570	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	S	Direct

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), purchase period of May 1, 2012 to October 31, 2012.